Equatorial Guinea, a multidrug-resistant tuberculosis hotspot in Central Africa

Eur Respir J. 2017 Jan 11;49(1):1600952. doi: 10.1183/13993003.00952-2016. Print 2017 Jan.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use*
  • Communicable Disease Control*
  • Drug Resistance, Bacterial
  • Equatorial Guinea / epidemiology
  • Female
  • Geography
  • HIV Seropositivity
  • Humans
  • Infectious Disease Medicine
  • Male
  • Mycobacterium tuberculosis
  • Recurrence
  • Rifampin / pharmacology
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology*
  • Young Adult

Substances

  • Antitubercular Agents
  • Rifampin